Company Overview
Snapshot
Founded in April 2015 by Ofer Yodfat and Guy Shinar, Triple Jump operates with 11–50 employees. The company has secured funding across one round from four investors, with Medtronic identified as a lead investor. In September 2020, Medtronic invested $20 million in the company.
Business overview
Triple Jump is an Israeli Health Tech & Life Sciences company focused on developing innovative medical devices for diabetes management. The company's core product is a compact, fully portable, battery-operated miniature insulin pump patch designed for patients with diabetes. This patch features mobile connectivity capabilities and is intended for integration into future artificial pancreas systems. Triple Jump serves the healthcare industry, specifically targeting patients with diabetes, and operates within the Drug Delivery and Medical Treatment & Therapeutics sectors.
Strategic signal
In October 2021, Medtronic was reportedly in talks to acquire Triple Jump for $300 million. This indicates significant strategic interest from a major medical device company in Triple Jump's insulin pump technology, signaling strong market validation and potential for a substantial exit for investors.
Log in to access full profile ›Company Intelligence Q&A
- When was Triple Jump founded and by whom?
- Triple Jump was founded in April 2015 by Ofer Yodfat and Guy Shinar.
- Which company made a significant investment in Triple Jump?
- In September 2020, Medtronic invested $20 million in Triple Jump, as reported by Calcalistech.com.
- What was the reported acquisition interest in Triple Jump?
- In October 2021, Medtronic was reportedly in talks to acquire Triple Jump for $300 million.
- What is the employee count for Triple Jump?
- Triple Jump has 11–50 employees.